Naz Rahman

Stock Analyst at Maxim Group

(0)
# 4586
Out of 5,356 analysts
51
Total ratings
20.00%
Success rate
-15.21%
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
GLMD Galmed Pharmaceutica...
Downgrades: Hold
n/a
n/a n/a 1 Apr 4, 2025
NVCT Nuvectis Pharma
Initiates Coverage On: Buy
17
8.94 90.16% 1 Apr 2, 2025
SLXN Silexion Therapeutic...
Maintains: Buy
9 5
0.91 449.45% 2 Mar 20, 2025
SCPH scPharmaceuticals
Maintains: Buy
20 12
4.11 191.97% 3 Mar 20, 2025
VKTX Viking Therapeutics
Maintains: Buy
120 70
27.02 159.07% 5 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 4 Nov 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 8
0.72 1011.11% 7 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.66 354.55% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
525 140
8.8 1490.91% 2 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.5 233.33% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
2.32 158.62% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
n/a n/a 1 Mar 31, 2021